Jiangsu Apon Medical Technology Co., Ltd.

Symbol: 300753.SZ

SHZ

12.98

CNY

Market price today

  • -103.9099

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 1.64B

    MRK Cap

  • 0.00%

    DIV Yield

Jiangsu Apon Medical Technology Co., Ltd. (300753-SZ) Financial Statements

On the chart you can see the default numbers in dynamics for Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Jiangsu Apon Medical Technology Co., Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014

balance-sheet.row.cash-and-short-term-investments

0249.3274.7388.6
420.6
436.1
169.8
141.7
74.1
12.2

balance-sheet.row.short-term-investments

0-22.7-7.6-1.5
-0.9
-1.5
0
0
0
0

balance-sheet.row.net-receivables

0133.6139.2102.3
90.7
55.2
39.9
37.3
36.4
30.5

balance-sheet.row.inventory

06167.431.7
27.9
25.4
24.3
20.9
13.2
13.4

balance-sheet.row.other-current-assets

01.52.90.7
0.3
1.2
0.4
1.2
4.4
25.5

balance-sheet.row.total-current-assets

0445.4484.2523.3
539.5
517.9
234.4
201.1
128
81.5

balance-sheet.row.property-plant-equipment-net

0207212.8168.6
143.7
99.2
38.1
39.2
31.5
31.7

balance-sheet.row.goodwill

053.269.433.9
16.5
16.5
16.5
16.5
0
0

balance-sheet.row.intangible-assets

035.633.237.7
43
32.5
37.5
32.5
2
2.1

balance-sheet.row.goodwill-and-intangible-assets

088.8102.671.6
59.5
49
54
49
2
2.1

balance-sheet.row.long-term-investments

0103.88760.5
7.8
2.5
3.4
2.8
0.5
0

balance-sheet.row.tax-assets

024.48.72.1
3.2
3.1
2.4
2.3
2.3
0.1

balance-sheet.row.other-non-current-assets

00.83.71.2
3.9
16.3
4.3
3
16.5
0.5

balance-sheet.row.total-non-current-assets

0424.8414.9303.9
218.2
170.1
98.8
93.4
52.2
34.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0

balance-sheet.row.total-assets

0870.2899.1827.2
757.6
688
333.3
294.5
180.3
115.8

balance-sheet.row.account-payables

046.927.831.4
30.4
29.1
4.7
4.3
2.3
5.9

balance-sheet.row.short-term-debt

033.82-3.4
-5.2
0
0
0
3
3

balance-sheet.row.tax-payables

06.68.514.5
14.3
5.9
8.9
10.8
10.2
8.9

balance-sheet.row.long-term-debt-total

034.539.93.7
0
0
0
0
0
0

Deferred Revenue Non Current

01.922
2
2.5
0.7
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-

balance-sheet.row.other-current-liab

01.642.353.8
49.8
42.9
48.5
60.6
29.5
25.5

balance-sheet.row.total-non-current-liabilities

036.7422.2
2.5
2.6
0.7
0
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

034.539.93.7
0
0
0
0
0
0

balance-sheet.row.total-liab

0183.9118.587.4
82.8
74.6
53.9
64.9
34.9
34.4

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0

balance-sheet.row.common-stock

0126126105
80.8
80.8
60.6
60.6
28.6
26.7

balance-sheet.row.retained-earnings

0188.1264.5247.1
191.4
132.6
68.7
26.3
55.8
37.1

balance-sheet.row.accumulated-other-comprehensive-income-loss

041.541.536.5
27.5
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0329.9347.6350.9
375.2
391.4
142.6
137
56.6
13.7

balance-sheet.row.total-stockholders-equity

0685.6779.6739.5
674.9
604.9
271.8
223.9
141
77.5

balance-sheet.row.total-liabilities-and-stockholders-equity

0870.2899.1827.2
757.6
688
333.3
294.5
180.3
115.8

balance-sheet.row.minority-interest

00.80.90.3
0
8.5
7.5
5.7
4.4
3.9

balance-sheet.row.total-equity

0686.4780.5739.8
674.9
613.4
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-

Total Investments

081.179.459
6.9
1
1.6
1.9
0
0

balance-sheet.row.total-debt

068.439.93.7
0
0
0
0
3
3

balance-sheet.row.net-debt

0-180.9-234.8-384.8
-420.6
-436.1
-169.8
-141.7
-71.1
-9.2

Cash Flow Statement

The financial landscape of Jiangsu Apon Medical Technology Co., Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014

cash-flows.row.net-income

0-76.553.396.9
102.8
71.1
60.2
49.3
29.7
0

cash-flows.row.depreciation-and-amortization

019.615.49.7
9.7
9.2
9
8.7
3
0

cash-flows.row.deferred-income-tax

0-15.5-6.60.7
0.2
0
0
0
0
0

cash-flows.row.stock-based-compensation

015.56.6-0.7
-0.2
0
0
0
0
0

cash-flows.row.change-in-working-capital

028.3-76.7-25.8
-18.6
-5
-2.1
5
-10.1
0

cash-flows.row.account-receivables

09.1-47.6-34
-43
0
0
0
0
0

cash-flows.row.inventory

06.3-33.6-3.3
-7.6
-1.1
-3.5
-4.1
0.2
0

cash-flows.row.account-payables

028.411.110.7
31.8
0
0
0
0
0

cash-flows.row.other-working-capital

0-15.5-6.60.7
0.2
-3.9
1.4
9.2
-10.3
0

cash-flows.row.other-non-cash-items

04.126.32.6
-16.4
2.9
-0.1
-2.1
15.5
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-24.2-39.6-35.6
-58.3
-61.6
-15.7
-4.3
-3.1
-2.7

cash-flows.row.acquisitions-net

00.1-37.32.7
7.2
-11.2
-14
-20.6
-16
0

cash-flows.row.purchases-of-investments

0-3-22.5-52.4
-6.6
0
-166
-157.5
-27.4
-63.1

cash-flows.row.sales-maturities-of-investments

02590.10.8
0.1
0
167.2
160.8
48.8
57.6

cash-flows.row.other-investing-activites

0-256.72.51.5
0.5
0
0
1.4
1.7
-1.4

cash-flows.row.net-cash-used-for-investing-activites

0-24.8-96.7-83.1
-57.1
-72.8
-28.4
-20.3
4
-9.5

cash-flows.row.debt-repayment

0-29.40-0.4
0
0
0
-3
-3
-15

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-0.6-31.5-32.3
-32.3
0
-10
-16.2
-7.1
-3.4

cash-flows.row.other-financing-activites

054-4.30.4
-3.8
260.7
-0.4
45.9
30
1.1

cash-flows.row.net-cash-used-provided-by-financing-activities

023.9-35.8-32.3
-36.1
260.7
-10.4
26.7
19.8
-17.3

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0.3
-0.1
0.2
0
0

cash-flows.row.net-change-in-cash

0-25.5-114.3-32
-15.5
266.3
28.1
67.6
61.9
6.7

cash-flows.row.cash-at-end-of-period

0248.8274.3388.6
420.6
436.1
169.8
141.7
74.1
12.2

cash-flows.row.cash-at-beginning-of-period

0274.3388.6420.6
436.1
169.8
141.7
74.1
12.2
5.4

cash-flows.row.operating-cash-flow

0-24.618.383.3
77.6
78.1
67.1
61
38.1
0

cash-flows.row.capital-expenditure

0-24.2-39.6-35.6
-58.3
-61.6
-15.7
-4.3
-3.1
-2.7

cash-flows.row.free-cash-flow

0-48.8-21.347.7
19.3
16.5
51.4
56.6
35
-2.7

Income Statement Row

Jiangsu Apon Medical Technology Co., Ltd.'s revenue saw a change of NaN% compared with the previous period. The gross profit of 300753.SZ is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014

income-statement-row.row.total-revenue

0323.8461.2443.1
379.6
298
246.9
198.3
153.5
120.4

income-statement-row.row.cost-of-revenue

0163.8166.3188.6
112
70
62.3
50.9
40.1
33.9

income-statement-row.row.gross-profit

0160294.9254.5
267.6
228
184.6
147.4
113.4
86.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-2.4-0.5-1.6
-2.9
-1.8
-0.9
8.4
6.1
4.2

income-statement-row.row.operating-expenses

0232235.5146.3
171.9
141.4
115
100.7
85.2
50.5

income-statement-row.row.cost-and-expenses

0395.7401.8334.9
283.9
211.5
177.3
151.7
125.3
84.3

income-statement-row.row.interest-income

02.13.67.2
7.4
1
0.3
0.1
0
0

income-statement-row.row.interest-expense

02.51.10
0.1
1.1
0.1
0
0.1
0.7

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-2.4-0.5-1.6
-2.9
-1.8
-0.9
8.4
6.1
4.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-2.4-0.5-1.6
-2.9
-1.8
-0.9
8.4
6.1
4.2

income-statement-row.row.total-operating-expenses

0-2.4-0.5-1.6
-2.9
-1.8
-0.9
8.4
6.1
4.2

income-statement-row.row.interest-expense

02.51.10
0.1
1.1
0.1
0
0.1
0.7

income-statement-row.row.depreciation-and-amortization

019.615.49.7
9.7
9.2
9
8.7
3
2.2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-

income-statement-row.row.operating-income

0-88.355.8113.5
120.7
85.6
70.7
49.1
27.3
34.8

income-statement-row.row.income-before-tax

0-90.755.3111.9
117.8
83.7
69.8
57.5
33.4
39

income-statement-row.row.income-tax-expense

0-14.2215
15
12.7
9.6
8.2
3.7
6.8

income-statement-row.row.net-income

0-76.454.197
102.3
70.1
57.9
47.7
28.9
31.4

Frequently Asked Question

What is Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) total assets?

Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) total assets is 870213234.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.567.

What is company free cash flow?

The free cash flow is -0.266.

What is enterprise net profit margin?

The net profit margin is -0.043.

What is firm total revenue?

The total revenue is -0.061.

What is Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) net profit (net income)?

The net profit (net income) is -76377405.540.

What is firm total debt?

The total debt is 68373296.000.

What is operating expences number?

The operating expences are 231973871.000.

What is company cash figure?

Enretprise cash is 0.000.